Actively Recruiting
Evaluation of the EchoMap 3D Ultrasound Device for Supporting Hemodialysis Cannulation in Adults with AV Fistulas
Led by Sonavex, Inc. · Updated on 2026-10-27
20
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the EchoMap device to assist with traditional methods of arteriovenous AV fistula cannulation in adults undergoing dialysis. This prospective, single-arm, multi-center feasibility study aims to improve cannulation by using 3D ultrasound technology in support of standard care. The study focuses on adults aged 18 to 85 years who have mature AV fistulas requiring cannulation. Participants will be assigned to groups in a crossover design where the EchoMap device supports standard cannulation techniques during certain dialysis sessions, while standard care alone is used in others. Different groups alternate the use of the EchoMap device across dialysis sessions 1 to 12. Some participants may receive only standard cannulation throughout. The device is intended to aid healthcare providers but not replace current methods. During the study, participants will undergo multiple dialysis sessions where cannulation is performed with or without EchoMap support. Researchers will track outcomes such as successful cannulation, number of needle sticks and advancements, infiltration incidents, hematoma severity, missed dialysis sessions, central venous catheter use and placement, bloodstream infections, and device-related adverse events. Patient and cannulator experiences will also be evaluated. The study is expected to last up to 24 weeks, with ongoing safety and effectiveness monitoring.
CONDITIONS
Brief Title
Study of 3D Ultrasound for Support of Hemodialysis Cannulation
Research Team
R
R Del Negro
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here